Moleculin Biotech, Inc. Deferred Compensation Arrangement with Individual, Compensation Expense
Moleculin Biotech, Inc. (MBRX) reported Deferred Compensation Arrangement with Individual, Compensation Expense of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-21.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense · last filed 2019-02-21
- Moleculin Biotech, Inc. deferred compensation arrangement with individual, compensation expense for the quarter ending 2018-12-31 was $0.00.
- Moleculin Biotech, Inc. deferred compensation arrangement with individual, compensation expense for the quarter ending 2018-09-30 was $0.00.
- Moleculin Biotech, Inc. deferred compensation arrangement with individual, compensation expense for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- Moleculin Biotech, Inc. deferred compensation arrangement with individual, compensation expense for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- Moleculin Biotech, Inc. deferred compensation arrangement with individual, compensation expense for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- Moleculin Biotech, Inc. deferred compensation arrangement with individual, compensation expense for fiscal 2017 was $62.00K, a 28.74% decline from fiscal 2016.
- Moleculin Biotech, Inc. deferred compensation arrangement with individual, compensation expense for fiscal 2016 was $87.00K.
| Period end | Deferred Compensation Arrangement with Individual, Compensation Expense 3 month | Deferred Compensation Arrangement with Individual, Compensation Expense 6 month | Deferred Compensation Arrangement with Individual, Compensation Expense 9 month | Deferred Compensation Arrangement with Individual, Compensation Expense 12 month | Deferred Compensation Arrangement with Individual, Compensation Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $0.00 derived: sum of 2 quarters · filed 2019-02-21 | $0.00 derived: sum of 3 quarters · filed 2019-02-21 | $0.00 10-K · filed 2019-02-21 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $0.00 derived: sum of 2 quarters · filed 2018-11-13 | $0.00 10-Q · filed 2018-11-13 | $0.00 derived: sum of 4 quarters · filed 2019-02-21 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $0.00 10-Q · filed 2018-08-10 | $0.00 derived: sum of 3 quarters · filed 2019-02-21 | -$1.00K derived: sum of 4 quarters · filed 2019-02-21 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-14 | $0.00 derived: sum of 2 quarters · filed 2019-02-21 | -$1.00K derived: sum of 3 quarters · filed 2019-02-21 | $24.00K derived: sum of 4 quarters · filed 2019-02-21 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | -$1.00K derived: sum of 2 quarters · filed 2019-02-21 | $24.00K derived: sum of 3 quarters · filed 2019-02-21 | $62.00K 10-K · filed 2019-02-21 | |
| 2017-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $24.00K derived: sum of 2 quarters · filed 2018-11-13 | $62.00K 10-Q · filed 2018-11-13 | $61.00K derived: sum of 4 quarters · filed 2018-11-13 | |
| 2017-06-30 | $25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $63.00K 10-Q · filed 2018-08-10 | $62.00K derived: sum of 3 quarters · filed 2018-08-10 | $150.00K derived: sum of 4 quarters · filed 2018-08-10 | |
| 2017-03-31 | $38.00K 10-Q · filed 2018-05-14 | $37.00K derived: sum of 2 quarters · filed 2018-05-14 | $125.00K derived: sum of 3 quarters · filed 2018-05-14 | $125.00K derived: sum of 4 quarters · filed 2018-05-14 | |
| 2016-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $87.00K derived: sum of 2 quarters · filed 2018-03-28 | $87.00K derived: sum of 3 quarters · filed 2018-03-28 | $87.00K 10-K · filed 2018-03-28 | $87.50K 10-K · filed 2017-04-03 |
| 2016-09-30 | $88.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $88.00K derived: sum of 2 quarters · filed 2017-11-13 | $88.00K 10-Q · filed 2017-11-13 | ||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $0.00 10-Q · filed 2017-08-11 | |||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |